ArticleBMC nephrology2016

Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients.

Hai V Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.